ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,101.24
-0.29%
Dow Jones
44,424.25
-0.32%
US Dollar vs MXN
20.2749
0.00%
Brent Oil
77.625
0.00%
Bitcoin
104,828.39
0.09%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Pluristem Therapeutics Inc (PSTI) Cotización

Pluristem Therapeutics Inc

Pluristem Therapeutics Inc (PSTI)

NASDAQ
1.00
0.00
(0.00%)
Cerrado 26 Enero 3:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
Fuera de horario: -
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
1.00
Postura de Compra
0.99
Postura de Venta
1.05
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
5.389M
Precio Anterior
1.00
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
5,389,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.15
Beneficio por acción (BPA)
-3.88
turnover
326k
Beneficio neto
-20.89M

Acerca de Pluristem Therapeutics Inc

Pluristem Therapeutics Inc is a US-based company that acts as a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The lead indications are critical limb ischemia, recovery after surgery for femoral neck fract... Pluristem Therapeutics Inc is a US-based company that acts as a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The lead indications are critical limb ischemia, recovery after surgery for femoral neck fracture, and acute radiation syndrome. The company operations are focused on the research, development, clinical trials, and manufacturing of cell therapeutics and related technologies. Mostrar más

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sitio web
www.pluristem.com
Sede
Haifa, North, Isr
Fundado
-

PSTI Últimas noticias

Más noticias

Pluri CEO Issues Shareholder Update

HAIFA, Israel, July 25, 2022 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”) (formerly known as Pluristem Therapeutics, Inc.), a leading biotechnology...

25 Julio 2022
GlobeNewswire Inc.

Pluristem Therapeutics Inc. Changes its Name to “Pluri Inc.” Reflecting the Company’s Strategy to Leverage its Innovative 3D Cell-based Technology Platform to Additional Industries

As of July 26, 2022, Pluri’s stock will trade under the symbol PLURThe new name reflects the Company’s strategy to leverage its innovative 3D cell-based technology to a range of fields, developing...

25 Julio 2022
GlobeNewswire Inc.

Pluristem Reports Topline Results from its Phase III Study of Muscle Regeneration Following Hip Fracture Surgery

The Company will host an analyst and investor call to discuss the phase III muscle regeneration following hip fracture surgery topline results on July 14 at 9:00 a.m. ET; for registration:...

13 Julio 2022
GlobeNewswire Inc.

Pluristem and Tnuva to Ring Nasdaq Closing Bell in Honor of New Partnership

Closing Bell Ringing Ceremony Will Take Place on Monday, March 28 at 3:45 pm ET at Nasdaq MarketSite in Times Square, New York A live stream of the Nasdaq Closing Bell will be available at:...

28 Marzo 2022
GlobeNewswire Inc.

Pluristem Releases PLX-R18 Hematology Phase I Study Results: Data Show Increase in All Blood Lines and Reduction in Blood Transfusions

Results show the potential in the use of PLX-R18 for meaningful advantage over other existing and proposed treatments in post hematopoietic cell transplantation (HCT) patients.PLX-R18 reduced...

23 Marzo 2022
GlobeNewswire Inc.

Pluristem and Tnuva Appoint Food Tech Veteran Eyal Rosenthal as Chief Executive Officer of their New Joint Venture

HAIFA, Israel, March 08, 2022 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI), a leading biotechnology company (“Pluristem”), and Tnuva Group (“Tnuva Group” or...

08 Marzo 2022
GlobeNewswire Inc.

Pluristem CEO Issues Shareholder Update

HAIFA, Israel, March 02, 2022 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI), a leading biotechnology company, today issued an update to its shareholders from its...

02 Marzo 2022
GlobeNewswire Inc.

Pluristem Announce the Closing of its Collaboration with Tnuva Group to Establish Cultured Food Platform

Pluristem officially closed a deal with Israel’s largest food brand Tnuva on February 24 2022, cementing an innovative partnership in the fast-growing industry of food techPluristem and Tnuva are...

24 Febrero 2022
GlobeNewswire Inc.

Biotechnology Company Pluristem, and Israel’s Largest Food Producer Tnuva, Launch Landmark Collaboration to Establish Cultured Food Platform

Collaboration uniquely combines Pluristem’s technological expertise in mass-scale, cost-effective, consistent cell production with Tnuva’s power multipliers in consumer-packaged goods, research...

10 Enero 2022
GlobeNewswire Inc.

Pluristem Reports Topline Results from its Phase II Studies of Acute Respiratory Distress Syndrome Associated with COVID-19

HAIFA, Israel, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI) (the “Company”), a leading biotechnology company, today announced topline results from its...

27 Diciembre 2021
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

PSTI - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Pluristem Therapeutics?
El precio actual de las acciones de Pluristem Therapeutics es US$ 1.00
¿Cuántas acciones de Pluristem Therapeutics están en circulación?
Pluristem Therapeutics tiene 5,389,000 acciones en circulación
¿Cuál es la capitalización de mercado de Pluristem Therapeutics?
La capitalización de mercado de Pluristem Therapeutics es USD 5.39M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Pluristem Therapeutics?
Pluristem Therapeutics ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Pluristem Therapeutics?
El ratio precio/beneficio de Pluristem Therapeutics es -1.15
¿Cuál es el ratio de efectivo a ventas de Pluristem Therapeutics?
El ratio de efectivo a ventas de Pluristem Therapeutics es 73.39
¿Cuál es la moneda de reporte de Pluristem Therapeutics?
Pluristem Therapeutics presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Pluristem Therapeutics?
El último ingresos anual de Pluristem Therapeutics es USD 326k
¿Cuál es el último beneficio anual de Pluristem Therapeutics?
El último beneficio anual de Pluristem Therapeutics es USD -20.89M
¿Cuál es la dirección registrada de Pluristem Therapeutics?
La dirección registrada de Pluristem Therapeutics es MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, NORTH, 3508409
¿Cuál es la dirección del sitio web de Pluristem Therapeutics?
La dirección del sitio web de Pluristem Therapeutics es www.pluristem.com
¿En qué sector industrial opera Pluristem Therapeutics?
Pluristem Therapeutics opera en el sector BIOLOGICAL PDS,EX DIAGNSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
EVAXEvaxion Biotech AS
US$ 5.99
(64.56%)
55.41M
ELABPMGC Holdings Inc
US$ 3.0901
(56.07%)
76.48M
PCLAPicoCELA Inc
US$ 4.60
(49.35%)
3.75M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
GODNUGolden Star Acquisition Corporation
US$ 3.11
(-75.82%)
17.51k
GODNGolden Star Acquisition Corporation
US$ 2.93
(-65.67%)
902.76k
NXTTNext Technology Holding Inc
US$ 1.37
(-54.93%)
2.56M
SGLYSingularity Future Technology Ltd
US$ 1.625
(-38.45%)
917.77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90.11
(-38.07%)
8
ACONAclarion Inc
US$ 0.0557
(28.94%)
811.91M
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
RIMEAlgorhythm Holdings Inc
US$ 0.0357
(4.69%)
284.97M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
NVDANVIDIA Corporation
US$ 142.62
(-3.12%)
232.88M

PSTI Discussion

Ver más
sekander sekander 10 meses hace
The new PLUR board is an absolute joke. Only one poster (guess who).
Just an attempt at getting away from the truth about this sham company
and roping in unsuspecting newbies.
👍️ 1
sekander sekander 10 meses hace
Down 20% on no volume since the reverse split. What an absolute turd.
👍️ 1
sekander sekander 10 meses hace
You've been spouting hoopla for 10 years and not one positive thing has ever
come from any of it. You must be getting paid awfully well to keep at it all these years.
👍️ 1
FDApproved FDApproved 10 meses hace
New Investor Hub Pluri Biotech Board Created !!! Head On Over...It's Where The Smart Money Lives & Breathes... All Things Pluri !!!
Enter Ticker Symbol PLUR In Search !!!
👍️ 1
sekander sekander 10 meses hace
Garbage knows only one way to go...Down!! The plummet continues.
This criminal enterprise will be lucky to hold a buck by the
end of the month. Unless they find some new saps.
👍️0
Scott999 Scott999 10 meses hace
Oh they’ll never abandon the sinking ship. They have 150 employees plugging the holes. Kaki has his harem of ladies, Zami’s like an OG gangster smoking some high end Cohibas with Doron Shorer slurping up some matzo balls laughing at the people who’s money they’ve scammed.

This is a half a billion dollar swindling by pros. Trying their best to rinse wash repeat. Taking millions upon millions from their countrymen. Will they get to a billion is what I wonder. There’s endless pretend indications they haven’t announced yet so who knows. They’re going on tour to get some fresh blood. Kaki and his harem are going to have a hedonistic world tour. Kaki will snap his fingers and 5 female employees bob on him like they’re trying to blow up a yo-yo.
👍️0
sekander sekander 10 meses hace
Rats deserting a sinking ship. Look out below!
👍️0
sekander sekander 10 meses hace
Gaining traction. What a laugh. If they were gaining traction, they wouldn't\
need a reverse split. More like stuck in the mud.
😀 1
FDApproved FDApproved 10 meses hace
Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences

https://pluri-biotech.com/wp-content/uploads/2024/03/1711621213_1711614542_Pluri_PR_re_Conferences_FINAL_FOR_RELEASE.pdf
👍️ 1
sekander sekander 10 meses hace
Gee, what a surprise! The only surprise is how they lasted this long without the dreaded RS.
Now, we're on to fake coffee. What happened to fake meat? But its all good with a fake company.
They will never run out of options as long as there are gullible idiots ready to buy into their hoopla.
👍️0
Scott999 Scott999 10 meses hace
And the hammer falls. Will only be a matter of a few months and they’ll be sub $1 again. Wow who could have seen this rs coming. Why didn’t I get an email about this news release.

But remember what Zzatt said the last rs. He’s seen it happen before when a rs was good for the stock. That was when he was buying hand over fist in the $20’s. But maybe this time will be different.

We got Zzientists!!! WE GOT ZZIENTISTS.
👍️ 1
FDApproved FDApproved 10 meses hace
Pluri Inc. Announces 1-for-8 Reverse Share Split

https://pluri-biotech.com/wp-content/uploads/2024/03/1711469825_1711439642_Pluri_PR_Reverse_Split_FINAL_FOR_RELEASE.pdf
👍️ 1
FDApproved FDApproved 10 meses hace
Pluri’s proprietary method for producing coffee aims to produce a better product with regards to taste, texture, scent, and sustainability,” stated Pluri’s CEO and President Yaky Yanay. “Our solution can help the industry produce coffee in a stable and controlled environment, ensuring consistent availability, price stability and saving everyone’s favorite beverage.”

https://pluri-biotech.com/wp-content/uploads/2024/03/1711007657_1710964082_ICO_report_FINAL_FOR_RELEASE.pdf
👍️ 1
FDApproved FDApproved 10 meses hace
Pluri CFO Interview

👍️ 1
FDApproved FDApproved 10 meses hace
The growing process begins by extracting coffee cells from the plant’s beans and leaves. These cells are placed into bioreactors to grow what Michal Ogolnik, head of Pluri’s coffee vertical, refers to as coffee “slivers.”

https://www.israel21c.org/your-next-cup-of-coffee-may-come-from-a-lab/
👍️ 1
FDApproved FDApproved 10 meses hace

Pluri (PLUR) Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing

https://www.streetinsider.com/Corporate+News/Pluri+%28PLUR%29+Selected+as+CDMO+by+Remedy+Cell+for+Cell-Derived+Cell-Free+Drug+Manufacturing/22929358.html
👍️ 1
FDApproved FDApproved 10 meses hace
Article Out Today On Pluri !!!

https://www.genengnews.com/topics/bioprocessing/improving-cell-therapy-supply-chains/
👍️ 1
FDApproved FDApproved 11 meses hace
Pluri (PLUR) Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation

https://www.streetinsider.com/Corporate+News/Pluri+%28PLUR%29+Receives+First-Ever+Patent+Approval+for+3D+Bioreactor+Technology+in+Plant+Cell+Cultivation/22910521.html
👍️ 1
FDApproved FDApproved 11 meses hace
Yaky Interview:

👍️ 1
FDApproved FDApproved 11 meses hace
Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board

https://pluri-biotech.com/wp-content/uploads/2024/03/1709724371_1709723044_Pluri_PR_re._Announces_Roosevelt_FINAL_FOR_RELEASE.pdf
👍️ 1
FDApproved FDApproved 11 meses hace
PLURI CDMO: While we already started generating revenues from this division, we are receiving a lot of additional interest and are currently negotiating several CDMO agreements.

https://www.globenewswire.com/news-release/2024/02/28/2836820/11974/en/Pluri-s-Innovation-Across-Various-Industries-CEO-Updates-on-Recent-Achievements-2024-Goals.html
👍️ 1
Scott999 Scott999 11 meses hace
Even if every share traded each day was through the ATM it wouldn’t come close to covering their costs.
👍️0
FDApproved FDApproved 11 meses hace
Thanks For Being The Most Uninformed Shareholder On The Planet !!!
👍️ 1
Scott999 Scott999 11 meses hace
Look at their “Pluriapps” on page 9. They have the following listed. Marketing department came up with Pluriapps and probably got a bunch of bonuses for it.

ARS failed the first time but government threw them a whopping $4.2 million over 3 years to try again.

Osteoarthritis. What’s that in preclinical?

Cultured meat. Crickets since announced

Cultured fish. Was for future but getting desperate so thoughts are now “apps”

Cultured dairy. See above.

Cell based coffee. News release and nothing to show they can like everything else.

CDMO to be seen what small fish they can find since anyone with any credibility goes to the real CDMO’s

Cosmetics? First we’ve heard of that pipe dream.

Biologics? Isn’t osteoarthritis part of their biologics? Or this just stuff they haven’t dreamt up yet.
👍️0
Scott999 Scott999 11 meses hace
Yes that have cash of $31 million. Current liabilities of about $4.5 million. And can’t forget about that $24 million long term liability of that bank loan.

The end is closer than one may think. Even with them reactivating the ATM so they can sell shares for well under a buck, they’re not going to be able to keep funding their paycheques for too much longer.

But their number one goal is to blow through half a billion dollars with nothing to show for it.
👍️0
FDApproved FDApproved 11 meses hace
February Company Presentation Out !!!

https://pluri-biotech.com/wp-content/uploads/2024/02/Pluri-PPT-investor_Q1_2024-final.pdf
👍️ 1
FDApproved FDApproved 11 meses hace
Yaky Interview !!!

👍️ 2
Scott999 Scott999 11 meses hace
Almost blown through $500,000,000.00 and this is what they have to show for it. Can’t make this stuff up. And the massive DOD thing is $4.2 million over 3 years.

“Our recent successes include a landmark collaboration with Israel’s largest food producer, Tnuva Group, to create cultivated meat (the subsidiary is called Ever After Foods), and a $4.2 Million contract signed with the US NIAID and DOD to advance the development of PLX-R18 for Acute Radiation Syndrome, among other successes of course.”

What other “successes” are there? Thermo? CHA? Chart Industries? United Therapeutics? Chinese partner? Japanese Partner? LMAO at the clowns and the clowns who thing this company is well rein like good ole Zzatty boy.
👍️0
FDApproved FDApproved 11 meses hace
Interview with Yaky Yanay, CEO and President of Pluri

https://techbullion.com/new-initiation-in-cultivated-coffee-interview-with-yaky-yanay-ceo-and-president-of-pluri/
👍️ 2
FDApproved FDApproved 11 meses hace
This Fella Accumulated 2,457,996 Shares Of Pluri Between September 1st & December 31st 2023 !!! He is Locally Known As The >>> "Warren Buffet Of San Francisco" !!!
ALL ABORAD

https://www.sec.gov/Archives/edgar/data/1158780/000201204424000001/xslSCHEDULE_13G_X01/primary_doc.xml
👍️ 2
FDApproved FDApproved 12 meses hace
The smell of freshly brewed coffee is one of the most recognizable aromas in the world.

https://nocamels.com/2024/02/startup-sees-coffee-from-cells-as-future-of-sustainable-drinking/
👍️ 2
FDApproved FDApproved 12 meses hace
Regals Capital Management LP Exercised The 486,000 Warrants They Were Holding !!!

They Are All In....With 2,041, 939 Shares or 4.87 % Of The Company. Also David Slager Has 770,160 Shares Which Brings Their % of Ownership to 6.70 % Of Pluri Biotech

https://www.sec.gov/Archives/edgar/data/1158780/000121390024008977/ea192665-13ga2slager_pluri.htm
👍️ 1
FDApproved FDApproved 12 meses hace
FYI: Someone Bought 80,000 Shares Of PLUR in Israel This Morning Right At The Close !!!

https://market.tase.co.il/en/market_data/security/1121730/major_data
👍️ 1
Scott999 Scott999 12 meses hace
Been right all along. You’re still vying for your first win. Sadly for you, I have the clowns working on my side. Mines a metaphor whereas yours is most likely literal.
👍️0
FDApproved FDApproved 12 meses hace
You Will Never....Ever.... Have A Clue !!!

And For You....Well, You Know Why !!!
👍️ 1
Scott999 Scott999 12 meses hace
And the losses begin. That didn’t take long. But like pulling a badaid. Just get it over with and they can sell what’s left in a couple months for Pennie’s on the dollar.
👍️0
FDApproved FDApproved 12 meses hace
Just Out !!!

https://agfundernews.com/real-coffee-without-the-beans-pluri-deploys-plant-cell-culture-to-futureproof-coffee-supply-chain
👍️ 1
FDApproved FDApproved 12 meses hace
Very Informative Article !!!

https://www.jpost.com/business-and-innovation/article-783632
👍️ 1
Scott999 Scott999 12 meses hace
We now know who’ll be losing their shirt in a couple months. Like every Pluristem shareholder had since day 1
👍️0
FDApproved FDApproved 12 meses hace
Israeli Startup Pluri Launches Cell-Based Coffee Business with Industrial Production Capacity

Pluri will reveal its market launch timeline later this year, but its self-funded coffee initiative is open to investment soon.

https://www.greenqueen.com.hk/pluri-cell-based-lab-grown-coffee-climate-change/
👍️ 1
FDApproved FDApproved 12 meses hace
Now We Know Who Has Been Buying Shares !!!

MERCHANT ADVENTURE FUND, L.P. Bought 2.125 Million Shares

https://www.sec.gov/Archives/edgar/data/1158780/000173726024000001/xslSCHEDULE_13G_X01/primary_doc.xml
👍️ 1
Scott999 Scott999 12 meses hace
Always an endless amount of fake things to chase after I know. Here’s their partial list of failures and things that have disappeared into oblivion. Without ANY wins and at a cost of close to $450,000,000.00. Has to be the most amount of money ever spent on a company that does nothing. But this one will be different. LMAO.

This company would have been long gone if it weren’t for their fake Covid headfake that allowed them to raise a ridiculous amount of money duping investors out of their money.

CLI
IC
Preeclampsia
ARS
HIP
ARDS
IBD
PAH
Tendon injuries
Marijuana
Beurgers
Covid
GvHD
Chart
Sosei
NY Blood Center
Thermo Scientific
TES Holdings
United Therapeutics
CHA Deal
Japan partner
👍️0
FDApproved FDApproved 12 meses hace
Scotty Is Blown Away !!!

https://www.marketscreener.com/quote/stock/PLURI-INC-62637874/news/Pluri-Inc-Launches-New-Business-Division-Offering-Cell-Therapy-Manufacturing-Services-as-Contract-D-45693958/
👍️ 1
FDApproved FDApproved 12 meses hace
Scotty's Daily Reading !!!

https://thegreentechpreneur.com/2023/12/04/pluris-technology-is-making-sustainable-meat-a-reality/
👍️ 1
FDApproved FDApproved 12 meses hace
Scotty's Training Video!!!

👍️ 1
FDApproved FDApproved 12 meses hace
Pluri is the first company in Israel and one of the first in the world to enter the field of cultured coffee, which is still in its infancy. "We are the first player that will be able to bring industrial production and regulation in short times," Yaky Yanay.

https://www.ynet.co.il/digital/technews/article/byawcwptp
👍️ 1
FDApproved FDApproved 1 año hace
Last week, ICL Open unveiled a collaboration with Pluri to pioneer advanced bioactive carriers and biostimulants. This partnership aims to leverage natural delivery mechanisms within plants, boosting crop yields and fostering sustainability in agriculture.

"Pluri's unique cell line manufacturing technology is ideal for such development, and the marriage with ICL's mineral and biological plant nutrition solutions holds promise for a breakthrough in this field," ICL wrote on its LinkedIn page. "The resultant technological platform is expected to produce multiple novel plant nutrition solutions in the future."

https://www.jpost.com/business-and-innovation/article-783632
👍️ 2
Scott999 Scott999 1 año hace
Zzatt set a new goal of 1 million shares. He heard they hired another zzientist.
👍️0
sekander sekander 1 año hace
What;s with the volume??? One million shares traded already?/!#
👍️0
Scott999 Scott999 1 año hace
Oh they’ll be announcing tons of pretend things they can make. Their marketing department has finally gotten a job to do. So much so that they’re thinking of moving the entire company into this department. Aside from the ones purchasing clown noses of course
👍️0

Su Consulta Reciente

NASDAQ
PSTI
Pluristem Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados